Note that Mounjaro is the tirzepatide formulation FDA-approved specifically for type 2 diabetes, while Zepbound is indicated for weight management
But Byetta was a modest drug
Ten years later, 25% of those treated with gastric bypass, 50% of those treated with biliopancreatic diversion, and 5.5% of those treated with conventional medical therapy were diabetes-free
The most important risk factor is concomitant use of insulin or insulin secretagogues (sulfonylureas such as glipizide, glyburide, or glimepiride, and meglitinides such as repaglinide)
That's why I said like get it as part of a con metabolic panel
Learn about their mechanisms, benefits, risks, and the necessity of medical supervision